ClinicalTrials.gov 临床试验·· 1 天前AI 评分38
锂乳清酸盐10 mg/日治疗阿尔茨海默病与轻度认知障碍的18个月随机双盲安慰剂对照研究
A Prospective, Randomized, Placebo-Controlled Double Blind, 18 Month Study Evaluating the Efficacy and Tolerability of Lithium Orotate 10 mg Daily in Patients With Alzheimer's Disease and Mild Cognitive Impairment.
AI 导读
一项为期18个月的多中心随机双盲安慰剂对照试验将评估锂乳清酸盐(Lithium Orotate)5 mg每日两次在阿尔茨海默病(AD)和轻度认知障碍(MCI)患者中的疗效与耐受性,计划入组200例受试者,按1:1随机分组。
来源:ClinicalTrials.gov 临床试验 · clinicaltrials.gov